In vitro binding study for sevelamer carbonate for Europe submission [Regulatives / Guidelines]

posted by jansari  – India, 2023-02-24 16:24 (214 d 00:28 ago) – Posting: # 23474
Views: 1,236

Dear Divyen

❝ ❝ ❝ they given the reference of following of guidance documents of Europe:: Guideline for locally applied , locally acting product in Gestrointestinal trac(CPMP/EWP/239/95Rev.1,Cor.1*) and this guidance documents given the acceptance limit as +- 10percentage..

❝ Read the sentence again: In vitro similarity should be assessed with a ±10% acceptance range, unless otherwise justified.

we were already given justification based on this sentence.and explain that our study is passing within T/R ratio as per acceptance limit 0.9 to 1.1...but they are not accepting the same and again raised the now we are repeating the same study ,.
can I have your mail ID ?so I can detailed out the study detail which results we obtained in the study..and what exactly regulatory asked?

❝ Kindly refer Calcium acetate USFDA PSG.


Awaiting for your positive reply..:-


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
 Admin contact
22,761 posts in 4,775 threads, 1,628 registered users;
15 visitors (0 registered, 15 guests [including 5 identified bots]).
Forum time: 17:52 CEST (Europe/Vienna)

Whenever a theory appears to you as the only possible one,
take this as a sign that you have neither understood the theory
nor the problem which it was intended to solve.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz